| CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients AJ Rech, R Mick, S Martin, A Recio, NA Aqui, DJ Powell Jr, TA Colligon, ... Science translational medicine 4 (134), 134ra62-134ra62, 2012 | 376 | 2012 |
| Miltefosine promotes IFN-γ-dominated anti-leishmanial immune response P Wadhone, M Maiti, R Agarwal, V Kamat, S Martin, B Saha The journal of immunology 182 (11), 7146-7154, 2009 | 162 | 2009 |
| CD40 expression levels modulate regulatory T cells in Leishmania donovani infection S Martin, R Agarwal, G Murugaiyan, B Saha The Journal of Immunology 185 (1), 551-559, 2010 | 77 | 2010 |
| Identification and characterization of an alternative cancer-derived PD-L1 splice variant NB Hassounah, VS Malladi, Y Huang, SS Freeman, EM Beauchamp, ... Cancer Immunology, Immunotherapy 68, 407-420, 2019 | 70 | 2019 |
| The battle over mTOR: an emerging theatre in host–pathogen immunity S Martin, B Saha, JL Riley Public Library of Science 8 (9), e1002894, 2012 | 58 | 2012 |
| Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy M Bodas, N Jain, A Awasthi, S Martin, RK Penke Loka, D Dandekar, ... The Journal of Immunology 177 (7), 4636-4643, 2006 | 46 | 2006 |
| Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28 C Huang, S Martin, C Pfleger, J Du, JH Buckner, JA Bluestone, JL Riley, ... The Journal of Immunology 190 (9), 4470-4473, 2013 | 42 | 2013 |
| Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells TJ Haggerty, IS Dunn, LB Rose, EE Newton, S Martin, JL Riley, JT Kurnick Cancer immunology, immunotherapy 60, 133-144, 2011 | 37 | 2011 |
| CD40 signaling in CD8+ CD40+ T cells turns on contra-T regulatory cell functions S Martin, S Pahari, R Sudan, B Saha The Journal of Immunology 184 (10), 5510-5518, 2010 | 37 | 2010 |
| Levels of CD40 expression on dendritic cells dictate tumour growth or regression G Murugaiyan, S Martin, B Saha Clinical & Experimental Immunology 149 (1), 194-202, 2007 | 35 | 2007 |
| Fatigue life analysis of an exhaust mount WV Mars, JGR Kingston, A Muhr, S Martin, KW Wong Constitutive Models for Rubber IV, 23-30, 2017 | 20 | 2017 |
| CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green? T Ganapathy, R Radhakrishnan, S Sakshi, S Martin Cancer Immunology, Immunotherapy 72 (2), 277-286, 2023 | 18 | 2023 |
| Cytokines in the generation and function of regulatory T cell subsets in leishmaniasis S Ghosh, K Roy, R Rajalingam, S Martin, C Pal Cytokine 147, 155266, 2021 | 16 | 2021 |
| SEB-induced signaling in macrophages leads to biphasic TNF-α AA Khan, S Martin, B Saha Journal of Leucocyte Biology 83 (6), 1363-1369, 2008 | 14 | 2008 |
| Engineering off-the-shelf universal CAR T cells: A silver lining in the cloud M Muthuvel, H Srinivasan, L Louis, S Martin Cytokine 156, 155920, 2022 | 9 | 2022 |
| Leishmania S Adak Caister Academic Press, 2015 | 5 | 2015 |
| The human CD8β M-4 isoform dominant in effector memory T cells has distinct cytoplasmic motifs that confer unique properties D Thakral, MM Coman, A Bandyopadhyay, S Martin, JL Riley, ... Plos one 8 (3), e59374, 2013 | 5 | 2013 |
| Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis VB Liju, S Martin, LR Nath, GK Gopinadhan Nair, H Thayele Purayil Frontiers in Pharmacology 14, 1283694, 2023 | | 2023 |
| CD40 at the interface of Leishmania-Macrophage interaction A Sarode, A Rub, S Bandyopadhyay, S Khan, S Martin, A Sarkar, B Saha EUROPEAN JOURNAL OF IMMUNOLOGY 49, 12-12, 2019 | | 2019 |
| Abstract A56: Identification and characterization of an alternative cancer-derived PDL1 isoform NB Hassounah, S Freeman, EM Beauchamp, CS Pedamallu, S Koyama, ... Cancer Immunology Research 5 (3_Supplement), A56-A56, 2017 | | 2017 |
